Cleveland Biolabs (CBLI) Fonstein to Step Down as CEO, Will Remain Pres; Kogan Named Interim CEO
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Join SI Premium – FREE
Cleveland Biolabs (Nasdaq: CBLI) says Michael Fonstein will step down as the company's CEO, however will remain as President. The company has named COO Yakov Kogan as the interim CEO.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Qnity Electronics names Ken Rizvi as CFO, effective October 1
- Yum! Brands adds former HanesBrands CEO to its board
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
